Endo (ENDP) (EW) (FRC) (PG) (RS) (LM) Ratings, Price Targets

Endo Pharmaceuticals (NASDAQ: ENDP), Edwards Lifesciences (NYSE: EW), First Republic Bank (NYSE: FRC), Procter & Gamble (NYSE: PG), Reliance Steel & Aluminum (NYSE: RS) and Legg Mason, Inc. (NYSE: LM) ratings and price targets.

Jefferies Group (NYSE:JEF) reiterated its "Buy" rating on Endo Pharmaceuticals (ENDP).

Canaccord Genuity reiterated its "Buy" rating on Edwards Lifesciences (EW).

Jefferies Group reiterated its "Hold" rating on First Republic Bank (FRC).

Procter & Gamble (PG) was downgraded by BMO Capital Markets from an “Outperform” rating to a “Market Perform” rating.

Reliance Steel & Aluminum (RS) was downgraded by CLSA from an “Outperform” rating to an “Underperform” rating.

Legg Mason, Inc. (LM) was upgraded by Keefe, Bruyette & Woods, Inc from a “Market Perform” rating to an “Outperform” rating.

Pandora (P) (ENDP) (HERO) (MAIL) (NVLS) (PANL) (PBI) (SIG) Ratings Reiterated

Pandora Media (NYSE: P), Endo Pharmaceuticals (NASDAQ: ENDP), Hercules Offshore, Inc. (NASDAQ: HERO), Incredimail Ltd. (NASDAQ: MAIL), Novellus Systems, Inc. (NASDAQ: NVLS), Universal Display Co. (NASDAQ: PANL), Pitney Bowes Inc. (NYSE: PBI) and Signet Jewelers Ltd. (NYSE: SIG) had their ratings reiterated by analysts.

Morgan Stanley (NYSE:MS) reiterated an "Equal Weight" rating on Pandora Media (P).

Piper Jaffray (NYSE:PJC) reiterated an “Overweight” rating on Endo Pharmaceuticals (ENDP).

Jefferies (NYSE:JEF) reiterated a "Buy" rating on Hercules Offshore, Inc. (HERO).

Goldman Sachs (NYSE:GS) reiterated a "Buy" rating on Incredimail Ltd. (MAIL).

Stifel Nicolaus reiterated a "Hold" rating on Novellus Systems, Inc. (NVLS).

Gabelli reiterated a "Buy" rating on Universal Display Co. (PANL).

BMC Equities Research reiterated a "Buy" rating on Pitney Bowes Inc. (PBI).

JPMorgan Chase & Co. (NYSE:JPM) reiterated an “Overweight” rating on Signet Jewelers Ltd. (SIG).

Ratings of (DAL) (ENDP) (FLEX) (GPRO) (HP) Downgraded

Analysts downgraded ratings of Delta Air Lines (NYSE: DAL), Endo Pharmaceuticals (NASDAQ: ENDP), Flextronics International Ltd. (NASDAQ: FLEX), Gen-Probe Incorporated (NASDAQ: GPRO) and Helmerich & Payne (NYSE: HP) today.

Capstone downgraded Delta Air Lines (DAL) from a “hold” rating to a “sell” rating.

Duncan Williams downgraded Endo Pharmaceuticals (ENDP) to a “buy” rating. They have a price target of $51.00 on the company.

Argus analysts downgraded Flextronics International Ltd. (FLEX) from a “buy” rating to a “hold” rating.

Gleacher & Co. downgraded Gen-Probe Incorporated (GPRO) from a “buy” rating to a “neutral” rating.

Canaccord Genuity downgraded Helmerich & Payne (HP) from a “buy” rating to a “hold” rating.

Endo Pharmaceuticals (ENDP) (IACI) (CLUB) (TSM) Get Ratings Upgrades

InterActiveCorp (NASDAQ:IACI), Endo Pharmaceuticals (NASDAQ:ENDP), Town Sports International (NASDAQ:CLUB) and Taiwan Semiconductor (NYSE:TSM) all received ratings upgrades from various brokerages today.

InterActiveCorp (IACI) was upgraded by Citigroup (NYSE:C) from "Hold" to "Buy."

Endo Pharmaceuticals (ENDP) was added to the "Top Picks Live List" of Citigroup.

Town Sports International (CLUB) was upgraded from "Hold" to "Buy" at ThinkEquity.

Taiwan Semiconductor (TSM), whas was jumping today and getting a lot of trading volume, was added to Goldman Sachs' (NYSE:GS) "Conviction Buy list." They were trading at $13.21, gaining $0.65, or 5.18 percent, as of 2:28 PM EDT.

Endo (ENDP) Bids $2.9b for (AMMD)

Shares of American Medical Systems (NASDAQ:AMMD) are skyrocketing on news Endo Pharmaceuticals (NASDAQ:ENDP) made a bid of $30 a share for the company.

According to Endo, once the deal is closed it will increase the diversification of the company in services and medical devices. Combined revenue of the new entity will be approximately $3 billion.

American Medical will add products and services in gynecology and urology to Endo's drugs which treat cancer, pain and low testosterone.

The deal is expected to close in the latter part of the third quarter.

Endo was trading at $42.34, gaining $1.49, or 3.65 percent, as of 12:26 PM EDT. AMMD was trading at $29.46, up $7.13, or 31.93 percent.

Endo Pharmaceuticals' (NASDAQ:ENDP) Fortesta, Opana ER, Should Stabilize Company

Endo Pharmaceuticals (NASDAQ:ENDP) should be driven strongly on the approval of Fortesta and Opana ER, bringing stability to the overall business, according to Duncan Williams.

They said, "We remain bullish on the two pending catalysts for Fortesta (testosterone replacement) and 'crush-proof' Opana ER (pain). We believe that approval of these products should provide reassurance regarding management's execution and the stability of the overall business. We have also updated our model for the Qualitest acquisition, the latest IMS data, and the updated guidance. Our 2010 estimates are meaningfully above Consensus."

Duncan Williams maintains a "Strong Buy" on Endo Pharmaceuticals Holdings Inc., which closed Tuesday at $35.21, down $0.29, or 0.82 percent. Duncan has a price target of $46 on them.